Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Apr;33(2):133-9.
doi: 10.1007/s10545-009-9027-4. Epub 2010 Jan 27.

PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease

Marloes L C Hagemans  1 , Rolinda L Stigter, Carine I van Capelle, Nadine A M E van der Beek, Leon P F Winkel, Laura van Vliet, Wim C J Hop, Arnold J J Reuser, Auke Beishuizen, Ans T van der Ploeg
Affiliations
Clinical Trial

PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease

Marloes L C Hagemans et al. J Inherit Metab Dis. 2010 Apr.

Abstract

Screening of blood films for the presence of periodic acid-Schiff (PAS)-positive lymphocyte vacuoles is sometimes used to support the diagnosis of Pompe disease, but the actual diagnostic value is still unknown. We collected peripheral blood films from 65 untreated Pompe patients and 51 controls. Lymphocyte vacuolization was quantified using three methods: percentage vacuolated lymphocytes, percentage PAS-positive lymphocytes, and a PAS score depending on staining intensity. Diagnostic accuracy of the tests was assessed using receiver operating characteristic (ROC) curves. All three methods fully discerned classic infantile patients from controls. The mean values of patients with milder forms of Pompe disease were significantly higher than those of controls, but full separation was not obtained. The area under the ROC curve was 0.98 for the percentage vacuolated lymphocytes (optimal cutoff value 3; sensitivity 91%, specificity 96%) and 0.99 for the percentage PAS-positive lymphocytes and PAS score (optimal cutoff value 9; sensitivity 100%, specificity 98%). Our data indicate that PAS-stained blood films can be used as a reliable screening tool to support a diagnosis of Pompe disease. The percentage of PAS-positive lymphocytes is convenient for use in clinical practice but should always be interpreted in combination with other clinical and laboratory parameters.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Photomicrographs of blood films from patients with Pompe disease and a healthy control. a May-Grünwald/Giemsa-stained blood film of a late-onset Pompe patient showing a lymphocyte with two distinct vacuoles; b periodic acid-Schiff (PAS)-stained blood film of a healthy control (PAS score = 0); c PAS-stained blood film of a late-onset Pompe patient showing a lymphocyte with PAS-positive inclusions (PAS score = 2); d PAS-stained blood film of a patient with classic infantile Pompe disease showing a lymphocyte with a larger number of PAS-positive inclusions (PAS score = 3)
Fig. 2
Fig. 2
Dot plots of a percentage of vacuolated lymphocytes, b percentage periodic acid-Schiff (PAS)-positive lymphocytes, and c PAS scores of 65 patients with Pompe disease and 51 controls. 0 controls (n = 51); 1 classic infantile patients (n = 8); 2 children with Pompe disease (n = 16); 3 adults with Pompe disease (n = 41)
Fig. 3
Fig. 3
Receiver operating characteristic (ROC) curves for the percentage of vacuolated lymphocytes, percentage of periodic acid-Schiff (PAS)-positive lymphocytes, and PAS-score of 65 patients with Pompe disease and 51 controls. ——— percentage of vacuolated lymphocytes; •— —•— —• percentage of PAS positive lymphocytes; —— —— PAS score; •—•—• reference line
See this image and copyright information in PMC

References

    1. Anderson G, Smith VV, Malone M, Sebire NJ. Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2, 500 cases from a single centre. J Clin Pathol. 2005;58:1305–1310. doi: 10.1136/jcp.2005.027045. - DOI - PMC - PubMed
    1. Bain JB. Blood cells a practical guide. 2. Oxford: Blackwell Science; 1995. pp. 186–188.
    1. de Barsy T, Hers HG. Biochemical and ultrastructural study of leucocytes in type II glycogenosis. Arch Int Physiol Biochim. 1975;83:954–955. - PubMed
    1. Hayhoe FGJ, Quaglino D. Carbohydrates. Haematological cytochemistry. New York: Churchill Livingstone; 1980. pp. 50–67.
    1. Hirschhorn R, Reuser AJJ (2000) Glycogen Storage Disease type II; acid α-Glucosidase (Acid Maltase) deficiency. In: Scriver CR, Beaudet AL, Sly W, Valle D (eds) 8th edn, vol III. Mc Graw-Hill, New York, pp 3389–3420

Publication types

MeSH terms